SSIs offer risks, not benefits during pregnancy, study says

11/2/2012 | Medscape (free registration)

Taking selective serotonin reuptake inhibitors while pregnant raises a woman's risk of miscarriage, preterm birth and neonatal complications, researchers from Beth Israel Deaconess Medical Center reported. They said there isn't strong data showing benefits, either for mothers or infants, and advised women to discuss use of the medications with their health care practitioner.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL